Deficiency of innate-like T lymphocytes in chronic obstructive pulmonary disease

Por Szabó, Mariann, Sárosi, Veronika, Balikó, Zoltán, Bodó, Kornélia, Farkas, Nelli, Berki, Tímea, Engelmann, Péter
Publicado no Respir Res (2017)

Cigarette Smoke-Induced Pulmonary Inflammation Becomes Systemic by Circulating Extracellular Vesicles Containing Wnt5a and Inflammatory Cytokines

Por Feller, Diana, Kun, Jozsef, Ruzsics, Istvan, Rapp, Judit, Sarosi, Veronika, Kvell, Krisztian, Helyes, Zsuzsanna, Pongracz, Judit E.
Publicado no Front Immunol (2018)

Alteration in the Wnt microenvironment directly regulates molecular events leading to pulmonary senescence

Por Kovacs, Tamas, Csongei, Veronika, Feller, Diana, Ernszt, David, Smuk, Gabor, Sarosi, Veronika, Jakab, Laszlo, Kvell, Krisztian, Bartis, Domokos, Pongracz, Judit E
Publicado no Aging Cell (2014)

The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer: Fin...

Por Tolnay, Edina, Ghimessy, Áron Kristóf, Juhász, Erzsébet, Sztancsik, Zsuzsanna, Losonczy, György, Dombi, Péter, Vennes, Zsuzsanna, Helf, László, Csada, Edit, Sárosi, Veronika
Publicado no Oncol Lett (2019)

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, mult...

Por Markóczy, Zsolt, Sárosi, Veronika, Kudaba, Iveta, Gálffy, Gabriella, Turay, Ülkü Yilmaz, Demirkazik, Ahmet, Purkalne, Gunta, Somfay, Attila, Pápai-Székely, Zsolt, Rásó, Erzsébet, Ostoros, Gyula
Publicado no BMC Cancer (2018)